Clinical trial Recruiting at 1 site Observational Ages 18 to 60 Women only

Improving ultrasound diagnosis of adenomyosis

Official title: Validation and Optimisation of Ultrasound Diagnosis of Adenomyosis: a Prospective Observational Study

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06795711 · Data updated 2026-11-12

This study is trying to improve how well ultrasound can diagnose adenomyosis in women by looking at specific measurements of the uterus.

More Adenomyosis trials

Quick facts

Study typeObservational
Ages18 Years to 60 Years
SexWomen only
Enrollment465 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna, Bologna)
StatusRecruiting
StartedApril 4, 2022
Main results expectedDecember 31, 2024
Study endsMarch 31, 2025
Registry record updatedJanuary 28, 2025
Trial IDNCT06795711 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18 to 60 who can provide informed consent and are experiencing symptoms related to adenomyosis.

Probably not a fit

Patients who have undergone a hysterectomy, are virgins, have gynaecological oncology issues, or are menopausal may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to enhance the accuracy of ultrasound in diagnosing adenomyosis by establishing specific biometric parameters of the uterus. It will categorize patients into three groups based on their uterine conditions: those with adenomyosis, those with fibromatosis, and those with a normal uterus. The research focuses on the use of transvaginal ultrasound, a non-invasive diagnostic tool, to assess the prevalence of uterine abnormalities and their impact on reproductive health. By refining ultrasound criteria, the study seeks to improve diagnostic reliability and patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to more accurate diagnoses of adenomyosis, potentially improving treatment options and outcomes for affected patients.

How similar studies have gone: While transvaginal ultrasound is a well-established diagnostic tool, this specific approach to optimizing its use for adenomyosis is novel and has not been extensively tested in previous studies.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* age between 18 and 60;
* obtaining informed consent

Exclusion Criteria:

* Hysterectomised patients;
* Virgo patients (hymenal integrity);
* Patients reporting intolerance to transvaginal ultrasound;
* Gynaecological oncology;
* Recent pregnancy or childbirth (within 6 months);
* Menopausal patients

Where it's running

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Diego Raimondo, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Diego Raimondo, MD
  • Email: die.raimondo@gmail.com
  • Phone: +393290636618

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.